CISD1 and hepatocellular carcinoma: Overexpression of the CISD1 was correlated with poor survival in male HCC patients (OS HR = 1.85 (1.19-2.88), p = 0.0059; PFS HR = 1.49 (1.03-2.15), p = 0.032) and T3 stage HCC patients (OS HR = 2.51 (0.98-6.43), p = 0.047; PFS HR = 2.68 (1.2-6.43), p = 0.013) as shown in Table 1.